Skip to main content
Cancers logoLink to Cancers
. 2022 Sep 19;14(18):4525. doi: 10.3390/cancers14184525

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers 2021, 13, 6109

Dongyu Zhang 1,2,†, Neil J Shah 3,†, Michael Cook 4, Matthew Blackburn 4, Michael T Serzan 4, Shailesh Advani 5,6, Arnold L Potosky 7, Subha Madhavan 7,8, Anas Belouali 7,8, Michael B Atkins 5,7,*, Dejana Braithwaite 1,2,9,*
PMCID: PMC9496993  PMID: 36139703

Addition of Authors

Subha Madhavan (S.M.) and Anas Belouali (A.B.) were not included as authors in the published article [1]. The corrected Author Contributions Statement appears below. Subha Madhavan should be listed as the eighth author, between Arnold L. Potosky and Anas Belouali, and be affiliated with the “Georgetown Lombardi Comprehensive Cancer Center” and “Innovation Center for Biomedical Informatics, Georgetown University Medical Center” (affiliation number 7 and 8). Anas Belouali should be listed as the ninth author, between Subha Madhavan and Michael B. Atkins, and be affiliated with the “Georgetown Lombardi Comprehensive Cancer Center” and “Innovation Center for Biomedical Informatics, Georgetown University Medical Center” (affiliation number 7 and 8).

S.M. and A.B. made substantial contributions to this manuscript. S.M. and A.B. contributed to data curation and cleaning, database maintenance, and editing and review of the manuscript. S.M. also contributed to funding acquisition.

Additional Affiliation

The affiliation 8 is newly added:

8 Innovation Center for Biomedical Informatics, Georgetown University Medical Center, Washington, DC 20007, USA

The affiliation 9 should be updated to:

9 Department of Surgery, University of Florida, Gainesville, FL 32610, USA

Author Contributions: Conceptualization, D.Z. and D.B.; methodology, D.Z.; software, D.Z.; validation, D.Z., N.J.S., S.A., A.L.P., M.B.A. and D.B.; formal analysis, D.Z.; investigation, D.Z. and N.J.S.; resources, S.M., A.B. and M.B.A.; data curation, S.M., A.B., N.J.S. and M.B.A.; writing—original draft preparation, D.Z.; writing—review and editing, D.Z., N.J.S., M.C., M.B., M.T.S., S.A., A.L.P., S.M., A.B., M.B.A. and D.B.; visualization, D.Z.; supervision, M.B.A. and D.B.; funding acquisition, S.M. and M.B.A. All authors have read and agreed to the published version of the manuscript.

The authors apologize for any inconvenience caused and state that the scientific conclusions are unaffected. The original article has been updated.

Footnotes

Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  • 1.Zhang D., Shah N.J., Cook M., Blackburn M., Serzan M.T., Advani S., Potosky A.L., Madhavan S., Belouali A., Atkins M.B., et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. Cancers. 2021;13:6109. doi: 10.3390/cancers13236109. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES